ImageneBio (IMA) Accumulated Depreciation & Amortization (2020 - 2023)

Historic Accumulated Depreciation & Amortization for ImageneBio (IMA) over the last 4 years, with Q4 2023 value amounting to $2.7 million.

  • ImageneBio's Accumulated Depreciation & Amortization rose 4997.26% to $2.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.7 million, marking a year-over-year increase of 4997.26%. This contributed to the annual value of $2.7 million for FY2023, which is 4997.26% up from last year.
  • Latest data reveals that ImageneBio reported Accumulated Depreciation & Amortization of $2.7 million as of Q4 2023, which was up 4997.26% from $2.5 million recorded in Q3 2023.
  • In the past 5 years, ImageneBio's Accumulated Depreciation & Amortization ranged from a high of $2.7 million in Q4 2023 and a low of $617000.0 during Q1 2021
  • In the last 4 years, ImageneBio's Accumulated Depreciation & Amortization had a median value of $1.4 million in 2022 and averaged $1.5 million.
  • As far as peak fluctuations go, ImageneBio's Accumulated Depreciation & Amortization surged by 10324.15% in 2022, and later soared by 4997.26% in 2023.
  • ImageneBio's Accumulated Depreciation & Amortization (Quarter) stood at $688000.0 in 2020, then soared by 56.1% to $1.1 million in 2021, then soared by 69.93% to $1.8 million in 2022, then soared by 49.97% to $2.7 million in 2023.
  • Its Accumulated Depreciation & Amortization stands at $2.7 million for Q4 2023, versus $2.5 million for Q3 2023 and $2.3 million for Q2 2023.